Globus Medical Inc
NYSE:GMED
Intrinsic Value
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. [ Read More ]
The intrinsic value of one GMED stock under the Base Case scenario is 80.32 USD. Compared to the current market price of 53.64 USD, Globus Medical Inc is Undervalued by 33%.
Valuation Backtest
Globus Medical Inc
Run backtest to discover the historical profit from buying and selling GMED stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Globus Medical Inc's business.
What risks and challenges
does Globus Medical Inc face in the near future?
Summarize the latest earnings report
of Globus Medical Inc.
Provide P/E
for Globus Medical Inc and its competitors.
Balance Sheet Decomposition
Globus Medical Inc
Current Assets | 1.9B |
Cash & Short-Term Investments | 517.8m |
Receivables | 504.9m |
Other Current Assets | 892.7m |
Non-Current Assets | 3.2B |
Long-Term Investments | 75.4m |
PP&E | 647.7m |
Intangibles | 2.4B |
Other Non-Current Assets | 88.5m |
Current Liabilities | 392.3m |
Accounts Payable | 56.7m |
Accrued Liabilities | 252m |
Other Current Liabilities | 83.7m |
Non-Current Liabilities | 695.8m |
Long-Term Debt | 417.7m |
Other Non-Current Liabilities | 278m |
Earnings Waterfall
Globus Medical Inc
Revenue
|
1.6B
USD
|
Cost of Revenue
|
-548.2m
USD
|
Gross Profit
|
1B
USD
|
Operating Expenses
|
-818.5m
USD
|
Operating Income
|
201.9m
USD
|
Other Expenses
|
-79m
USD
|
Net Income
|
122.9m
USD
|
Free Cash Flow Analysis
Globus Medical Inc
What is Free Cash Flow?
GMED Profitability Score
Profitability Due Diligence
Globus Medical Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Globus Medical Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
GMED Solvency Score
Solvency Due Diligence
Globus Medical Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Globus Medical Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GMED Price Targets Summary
Globus Medical Inc
According to Wall Street analysts, the average 1-year price target for GMED is 62.81 USD with a low forecast of 25.25 USD and a high forecast of 87.15 USD.
Ownership
GMED Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
GMED Price
Globus Medical Inc
Average Annual Return | 10.64% |
Standard Deviation of Annual Returns | 9.74% |
Max Drawdown | -48% |
Market Capitalization | 7.3B USD |
Shares Outstanding | 135 370 000 |
Percentage of Shares Shorted | 5.12% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2012-03-08. The company is focused on implants that promote healing in patients with musculoskeletal disorders, including the use of a robotic guidance and navigation system and products to treat orthopedic traumas. The company groups its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities as well as the hip. Its Enabling Technologies are comprised of imaging, navigation, and robotics (INR) solutions for assisted surgery. The company offers solutions that facilitate both open and minimally invasive surgery (MIS) techniques. The company includes traditional fusion implants, such as pedicle screw and rod systems.
Contact
IPO
Employees
Officers
The intrinsic value of one GMED stock under the Base Case scenario is 80.32 USD.
Compared to the current market price of 53.64 USD, Globus Medical Inc is Undervalued by 33%.